Liu, Xuefeng http://orcid.org/0000-0002-9922-9627
Krawczyk, Ewa
Suprynowicz, Frank A
Palechor-Ceron, Nancy
Yuan, Hang
Dakic, Aleksandra
Simic, Vera
Zheng, Yun-Ling
Sripadhan, Praathibha
Chen, Chen
Lu, Jie
Hou, Tung-Wei
Choudhury, Sujata
Kallakury, Bhaskar
Tang, Dean G
Darling, Thomas
Thangapazham, Rajesh
Timofeeva, Olga
Dritschilo, Anatoly
Randell, Scott H
Albanese, Christopher
Agarwal, Seema
Schlegel, Richard
Article History
First Online: 26 January 2017
Change Date: 19 January 2018
Change Type: Corrigendum
Change Details: In the version of this article initially published, elements of two references were inadvertently combined as reference 3; these are now listed separately as references 3 and 52. Both references are now cited wherever reference 3 was cited in the article. The error has been corrected in the HTML and PDF versions of the article.
Change Date: 6 April 2017
Change Type: Corrigendum
Change Details: In the version of this article initially published, a middle initial was missing for one of the authors (Dean G. Tang). The error has been corrected in the HTML and PDF versions of the article.
Competing interests
: Georgetown University has been awarded a patent by the United States Patent Office (9,279,106) for conditional cell reprogramming. This technology has been licensed exclusively to a biotechnology company, Propagenix, for commercialization. Georgetown University and the inventors (X.L., R.S.) receive payments and potential royalties from Propagenix.